Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Not Confirmed
Not Confirmed
08-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Industry Trade Show
Not Confirmed
08-10 December, 2025
Digital content

25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048736/0/en/Eterna-Therapeutics-Changes-Name-to-Ernexa-Therapeutics-to-Reflect-New-Strategic-Focus-on-Ovarian-Cancer-and-Autoimmune-Disease.html

26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032931/0/en/Eterna-Therapeutics-Hosts-Successful-Inaugural-Meeting-with-Newly-Formed-Scientific-Advisory-Board-to-Advance-Cell-Therapy-Pipeline.html

28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016398/0/en/Eterna-Therapeutics-Announces-Expansion-of-Scientific-Advisory-Board.html

14 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/14/3009318/0/en/Eterna-Therapeutics-Announces-Positive-Preclinical-Study-Results-on-Lead-Product-ERNA-101-in-Ovarian-Cancer.html

09 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/09/3006981/0/en/Eterna-Therapeutics-Announces-Appointment-of-Dr-Elena-Ratner-to-Board-of-Directors.html

03 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/03/2990647/0/en/Eterna-Therapeutics-Launches-Research-to-Evaluate-its-Lead-Induced-Mesenchymal-Stem-Cell-Therapy-Candidate-s-ERNA-101-Ability-to-Induce-and-Modulate-Antitumor-Immunity-in-Ovarian-C.html
ABOUT THIS PAGE